Resistance Management Strategy for:
Group 2 (Dicarboximide);
Group 3 DMI (Demethylation Inhibitor);
Group 7 SDHI (Succinate dehydrogenase Inhibitors);
Group 7+3 (SDHI + DMI); and
Group 11+3 (Quinone outside Inhibitor + DMI).
Note: An application in the flowering period for the control of upper canopy infection (UCI) of blackleg should also be counted as an application for the control of sclerotinia, if conditions are conducive for sclerotinia infection or sclerotinia infection is already present.
Content last updated: July 2, 2019